Showing results (151-160 of 201) with videos related to

Sort By:
Pageof 21
BMC Cardiovascular Disorders|November 20, 2021
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillationLidia Staszewsky, Jennifer M T A Meessen, Deborah Novelli, et al.
Gene|July 23, 2019
Sequencing of NOTCH1 gene in an Italian population with bicuspid aortic valve: Preliminary results from the GISSI OUTLIERS VAR studySilvana Pileggi, Benedetta De Chiara, Michela Magnoli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 19, 2007
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trialRoberto Marchioli, Rosa Maria Marfisi, Giovanna Borrelli, et al.
European Journal of Human Genetics : EJHG|November 30, 2006
Multiple QTL influence the serum Lp(a) concentration: a genome-wide linkage screen in the PROCARDIS studySimona Barlera, Claudia Specchia, Martin Farrall, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 26, 2021
The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac SurgeryAndre Lamy, Wesley Tong, Rajibul Mian, et al.
European Journal of Clinical Investigation|June 1, 2011
Adiponectin in chronic heart failure: influence of diabetes and genetic variantsSerge Masson, Francesca Gori, Roberto Latini, et al.
Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.
Journal of Internal Medicine|October 23, 2010
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trialR Latini, S Masson, S Pirelli, et al.
Journal of Hypertension|November 4, 2006
High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarctionFausto Avanzini, Claudio Alli, Alessandro Boccanelli, et al.
American Heart Journal|March 3, 2009
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of riskCampbell D Joyner, Ron J G Peters, Rizwan Afzal, et al.
Pageof 21